-
your career by contributing to a world-leading systemic sclerosis research network and registry? The successful candidate will join the Scleroderma (also known as Systemic sclerosis; SSc) research team
-
, sustainable and net zero ambition for biogenically derived chemicals is a massive industry-wide challenge. Most solvents are petrochemically derived, and present one of the main wastes in pharma and fine
-
treatment due to its complexity. We will examine whether 3D assembloids, derived from cardiac-like, vascular-like, and brain-like structures, can more authentically model the human BBB and neurovascular unit
-
., AlphaFold) techniques, enabling the characterisation of complex and challenging systems involved in OMP chaperoning by SurA and delivery to BAM. You will be based in the laboratories of Dr Antonio Calabrese